Loading…

Resistance of staphylococci in The Netherlands : surveillance by an electronic network during 1989-1995

An electronic surveillance network for monitoring antibiotic resistance in The Netherlands has been in operation since 1989. Seven public health laboratories participate and the system covers about 25% of all bacteriological determinations in The Netherlands. This paper reports the results of staphy...

Full description

Saved in:
Bibliographic Details
Published in:Journal of antimicrobial chemotherapy 1998, Vol.41 (1), p.93-101
Main Authors: DE NEELING, A. J, VAN LEEUWEN, W. J, SABBE, L. J. M, VAN GRIETHUYSEN, A. J. A, VAN EMBDEN, J. D. A, SCHOULS, L. M, SCHOT, C. S, VAN VEEN-RUTGERS, A, BEUNDERS, A. J, BUITING, A. G. M, HOLD, C, LIGTVOET, E. E. J, PETIT, P. L
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c381t-3a50ee7ee7768ee64b5fef87935fa0b7e8e96708be3590b379d5f66f30a77e4f3
cites
container_end_page 101
container_issue 1
container_start_page 93
container_title Journal of antimicrobial chemotherapy
container_volume 41
creator DE NEELING, A. J
VAN LEEUWEN, W. J
SABBE, L. J. M
VAN GRIETHUYSEN, A. J. A
VAN EMBDEN, J. D. A
SCHOULS, L. M
SCHOT, C. S
VAN VEEN-RUTGERS, A
BEUNDERS, A. J
BUITING, A. G. M
HOLD, C
LIGTVOET, E. E. J
PETIT, P. L
description An electronic surveillance network for monitoring antibiotic resistance in The Netherlands has been in operation since 1989. Seven public health laboratories participate and the system covers about 25% of all bacteriological determinations in The Netherlands. This paper reports the results of staphylococci isolated in the period 1989-1995. About 0.3% of the Staphylococcus aureus isolates in the study period were resistant to methicillin. This low percentage may be due to the restrictive use of antibiotics and to strict isolation measures aimed at eradicating methicillin-resistant S. aureus. Low frequencies of resistance among methicillin-resistant S. aureus were found for vancomycin (0%), chloramphenicol (11%), cotrimoxazole (11%), mupirocin (3% low-level resistance) and fusidic acid (7%). Twenty-one percent of the coagulase-negative staphylococci were resistant to methicillin. Low frequencies of resistance among these methicillin-resistant coagulase-negative staphylococci were those to vancomycin (0.4%), nitrofurantoin (2%), doxycycline (20%) and amikacin (20%). Coagulase-negative staphylococci from cerebrospinal fluid, blood and skin were less often resistant to quinolones than isolates from respiratory tract, faeces and urine. A significant increase in resistance of coagulase-negative staphylococci to methicillin, erythromycin, gentamicin and ciprofloxacin was observed in the investigated period but the resistance to doxycycline and co-trimoxazole decreased in the last few years. To confirm the determination of methicillin resistance and coagulase production, a PCR method was developed which detects both the mecA and the coagulase gene. The results of the PCR method correlated well with the methicillin MIC as determined by an agar-dilution method.
doi_str_mv 10.1093/jac/41.1.93
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79735850</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16476578</sourcerecordid><originalsourceid>FETCH-LOGICAL-c381t-3a50ee7ee7768ee64b5fef87935fa0b7e8e96708be3590b379d5f66f30a77e4f3</originalsourceid><addsrcrecordid>eNqFkE1rGzEQhkVocB23p5wDOpRewjoj6zu3EJqkEFIo6Vlo5ZGtdL3rSLsp_vfdxCbXwMAMvM8Mw0PIKYM5A8svnny4EGzO5pYfkSkTCqoFWPaJTIGDrLSQ_DM5KeUJAJRUZkImVjIGYjElq99YUul9G5B2kY7Tdr1rutCFkGhq6eMa6QP2a8yNb5eFXtIy5BdMTfO2Uu-obyk2GPrctSnQFvt_Xf5Ll0NO7Yoya2zFrJVfyHH0TcGvhz4jf25-PF7fVfe_bn9eX91XgRvWV9xLQNRjaWUQlahlxGi05TJ6qDUatEqDqZFLCzXXdimjUpGD1xpF5DPyfX93m7vnAUvvNqkEfH0Xu6E4bTWXRsKHIFNCK6nNCJ7vwZC7UjJGt81p4_POMXCv_t3o3wnmmLN8pM8OZ4d6g8t39iB8zL8dcl-Cb2IeNabyji2YEAtp-X_V-Yzr</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16476578</pqid></control><display><type>article</type><title>Resistance of staphylococci in The Netherlands : surveillance by an electronic network during 1989-1995</title><source>Oxford Journals Online</source><creator>DE NEELING, A. J ; VAN LEEUWEN, W. J ; SABBE, L. J. M ; VAN GRIETHUYSEN, A. J. A ; VAN EMBDEN, J. D. A ; SCHOULS, L. M ; SCHOT, C. S ; VAN VEEN-RUTGERS, A ; BEUNDERS, A. J ; BUITING, A. G. M ; HOLD, C ; LIGTVOET, E. E. J ; PETIT, P. L</creator><creatorcontrib>DE NEELING, A. J ; VAN LEEUWEN, W. J ; SABBE, L. J. M ; VAN GRIETHUYSEN, A. J. A ; VAN EMBDEN, J. D. A ; SCHOULS, L. M ; SCHOT, C. S ; VAN VEEN-RUTGERS, A ; BEUNDERS, A. J ; BUITING, A. G. M ; HOLD, C ; LIGTVOET, E. E. J ; PETIT, P. L</creatorcontrib><description>An electronic surveillance network for monitoring antibiotic resistance in The Netherlands has been in operation since 1989. Seven public health laboratories participate and the system covers about 25% of all bacteriological determinations in The Netherlands. This paper reports the results of staphylococci isolated in the period 1989-1995. About 0.3% of the Staphylococcus aureus isolates in the study period were resistant to methicillin. This low percentage may be due to the restrictive use of antibiotics and to strict isolation measures aimed at eradicating methicillin-resistant S. aureus. Low frequencies of resistance among methicillin-resistant S. aureus were found for vancomycin (0%), chloramphenicol (11%), cotrimoxazole (11%), mupirocin (3% low-level resistance) and fusidic acid (7%). Twenty-one percent of the coagulase-negative staphylococci were resistant to methicillin. Low frequencies of resistance among these methicillin-resistant coagulase-negative staphylococci were those to vancomycin (0.4%), nitrofurantoin (2%), doxycycline (20%) and amikacin (20%). Coagulase-negative staphylococci from cerebrospinal fluid, blood and skin were less often resistant to quinolones than isolates from respiratory tract, faeces and urine. A significant increase in resistance of coagulase-negative staphylococci to methicillin, erythromycin, gentamicin and ciprofloxacin was observed in the investigated period but the resistance to doxycycline and co-trimoxazole decreased in the last few years. To confirm the determination of methicillin resistance and coagulase production, a PCR method was developed which detects both the mecA and the coagulase gene. The results of the PCR method correlated well with the methicillin MIC as determined by an agar-dilution method.</description><identifier>ISSN: 0305-7453</identifier><identifier>EISSN: 1460-2091</identifier><identifier>DOI: 10.1093/jac/41.1.93</identifier><identifier>PMID: 9511042</identifier><identifier>CODEN: JACHDX</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Anti-Bacterial Agents - pharmacology ; Antibacterial agents ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Bacterial Proteins ; Biological and medical sciences ; Carrier Proteins - genetics ; Coagulase - metabolism ; Disease Outbreaks ; Drug Resistance, Multiple - genetics ; Hexosyltransferases ; Humans ; Medical sciences ; Methicillin Resistance - genetics ; Microbial Sensitivity Tests ; Muramoylpentapeptide Carboxypeptidase - genetics ; Netherlands - epidemiology ; Penicillin-Binding Proteins ; Peptidyl Transferases ; Pharmacology. Drug treatments ; Polymerase Chain Reaction ; Population Surveillance ; Staphylococcal Infections - epidemiology ; Staphylococcus aureus - drug effects ; Staphylococcus aureus - enzymology ; Staphylococcus aureus - genetics</subject><ispartof>Journal of antimicrobial chemotherapy, 1998, Vol.41 (1), p.93-101</ispartof><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c381t-3a50ee7ee7768ee64b5fef87935fa0b7e8e96708be3590b379d5f66f30a77e4f3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2144259$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9511042$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>DE NEELING, A. J</creatorcontrib><creatorcontrib>VAN LEEUWEN, W. J</creatorcontrib><creatorcontrib>SABBE, L. J. M</creatorcontrib><creatorcontrib>VAN GRIETHUYSEN, A. J. A</creatorcontrib><creatorcontrib>VAN EMBDEN, J. D. A</creatorcontrib><creatorcontrib>SCHOULS, L. M</creatorcontrib><creatorcontrib>SCHOT, C. S</creatorcontrib><creatorcontrib>VAN VEEN-RUTGERS, A</creatorcontrib><creatorcontrib>BEUNDERS, A. J</creatorcontrib><creatorcontrib>BUITING, A. G. M</creatorcontrib><creatorcontrib>HOLD, C</creatorcontrib><creatorcontrib>LIGTVOET, E. E. J</creatorcontrib><creatorcontrib>PETIT, P. L</creatorcontrib><title>Resistance of staphylococci in The Netherlands : surveillance by an electronic network during 1989-1995</title><title>Journal of antimicrobial chemotherapy</title><addtitle>J Antimicrob Chemother</addtitle><description>An electronic surveillance network for monitoring antibiotic resistance in The Netherlands has been in operation since 1989. Seven public health laboratories participate and the system covers about 25% of all bacteriological determinations in The Netherlands. This paper reports the results of staphylococci isolated in the period 1989-1995. About 0.3% of the Staphylococcus aureus isolates in the study period were resistant to methicillin. This low percentage may be due to the restrictive use of antibiotics and to strict isolation measures aimed at eradicating methicillin-resistant S. aureus. Low frequencies of resistance among methicillin-resistant S. aureus were found for vancomycin (0%), chloramphenicol (11%), cotrimoxazole (11%), mupirocin (3% low-level resistance) and fusidic acid (7%). Twenty-one percent of the coagulase-negative staphylococci were resistant to methicillin. Low frequencies of resistance among these methicillin-resistant coagulase-negative staphylococci were those to vancomycin (0.4%), nitrofurantoin (2%), doxycycline (20%) and amikacin (20%). Coagulase-negative staphylococci from cerebrospinal fluid, blood and skin were less often resistant to quinolones than isolates from respiratory tract, faeces and urine. A significant increase in resistance of coagulase-negative staphylococci to methicillin, erythromycin, gentamicin and ciprofloxacin was observed in the investigated period but the resistance to doxycycline and co-trimoxazole decreased in the last few years. To confirm the determination of methicillin resistance and coagulase production, a PCR method was developed which detects both the mecA and the coagulase gene. The results of the PCR method correlated well with the methicillin MIC as determined by an agar-dilution method.</description><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Antibacterial agents</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Bacterial Proteins</subject><subject>Biological and medical sciences</subject><subject>Carrier Proteins - genetics</subject><subject>Coagulase - metabolism</subject><subject>Disease Outbreaks</subject><subject>Drug Resistance, Multiple - genetics</subject><subject>Hexosyltransferases</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Methicillin Resistance - genetics</subject><subject>Microbial Sensitivity Tests</subject><subject>Muramoylpentapeptide Carboxypeptidase - genetics</subject><subject>Netherlands - epidemiology</subject><subject>Penicillin-Binding Proteins</subject><subject>Peptidyl Transferases</subject><subject>Pharmacology. Drug treatments</subject><subject>Polymerase Chain Reaction</subject><subject>Population Surveillance</subject><subject>Staphylococcal Infections - epidemiology</subject><subject>Staphylococcus aureus - drug effects</subject><subject>Staphylococcus aureus - enzymology</subject><subject>Staphylococcus aureus - genetics</subject><issn>0305-7453</issn><issn>1460-2091</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNqFkE1rGzEQhkVocB23p5wDOpRewjoj6zu3EJqkEFIo6Vlo5ZGtdL3rSLsp_vfdxCbXwMAMvM8Mw0PIKYM5A8svnny4EGzO5pYfkSkTCqoFWPaJTIGDrLSQ_DM5KeUJAJRUZkImVjIGYjElq99YUul9G5B2kY7Tdr1rutCFkGhq6eMa6QP2a8yNb5eFXtIy5BdMTfO2Uu-obyk2GPrctSnQFvt_Xf5Ll0NO7Yoya2zFrJVfyHH0TcGvhz4jf25-PF7fVfe_bn9eX91XgRvWV9xLQNRjaWUQlahlxGi05TJ6qDUatEqDqZFLCzXXdimjUpGD1xpF5DPyfX93m7vnAUvvNqkEfH0Xu6E4bTWXRsKHIFNCK6nNCJ7vwZC7UjJGt81p4_POMXCv_t3o3wnmmLN8pM8OZ4d6g8t39iB8zL8dcl-Cb2IeNabyji2YEAtp-X_V-Yzr</recordid><startdate>1998</startdate><enddate>1998</enddate><creator>DE NEELING, A. J</creator><creator>VAN LEEUWEN, W. J</creator><creator>SABBE, L. J. M</creator><creator>VAN GRIETHUYSEN, A. J. A</creator><creator>VAN EMBDEN, J. D. A</creator><creator>SCHOULS, L. M</creator><creator>SCHOT, C. S</creator><creator>VAN VEEN-RUTGERS, A</creator><creator>BEUNDERS, A. J</creator><creator>BUITING, A. G. M</creator><creator>HOLD, C</creator><creator>LIGTVOET, E. E. J</creator><creator>PETIT, P. L</creator><general>Oxford University Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>1998</creationdate><title>Resistance of staphylococci in The Netherlands : surveillance by an electronic network during 1989-1995</title><author>DE NEELING, A. J ; VAN LEEUWEN, W. J ; SABBE, L. J. M ; VAN GRIETHUYSEN, A. J. A ; VAN EMBDEN, J. D. A ; SCHOULS, L. M ; SCHOT, C. S ; VAN VEEN-RUTGERS, A ; BEUNDERS, A. J ; BUITING, A. G. M ; HOLD, C ; LIGTVOET, E. E. J ; PETIT, P. L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c381t-3a50ee7ee7768ee64b5fef87935fa0b7e8e96708be3590b379d5f66f30a77e4f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Antibacterial agents</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Bacterial Proteins</topic><topic>Biological and medical sciences</topic><topic>Carrier Proteins - genetics</topic><topic>Coagulase - metabolism</topic><topic>Disease Outbreaks</topic><topic>Drug Resistance, Multiple - genetics</topic><topic>Hexosyltransferases</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Methicillin Resistance - genetics</topic><topic>Microbial Sensitivity Tests</topic><topic>Muramoylpentapeptide Carboxypeptidase - genetics</topic><topic>Netherlands - epidemiology</topic><topic>Penicillin-Binding Proteins</topic><topic>Peptidyl Transferases</topic><topic>Pharmacology. Drug treatments</topic><topic>Polymerase Chain Reaction</topic><topic>Population Surveillance</topic><topic>Staphylococcal Infections - epidemiology</topic><topic>Staphylococcus aureus - drug effects</topic><topic>Staphylococcus aureus - enzymology</topic><topic>Staphylococcus aureus - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>DE NEELING, A. J</creatorcontrib><creatorcontrib>VAN LEEUWEN, W. J</creatorcontrib><creatorcontrib>SABBE, L. J. M</creatorcontrib><creatorcontrib>VAN GRIETHUYSEN, A. J. A</creatorcontrib><creatorcontrib>VAN EMBDEN, J. D. A</creatorcontrib><creatorcontrib>SCHOULS, L. M</creatorcontrib><creatorcontrib>SCHOT, C. S</creatorcontrib><creatorcontrib>VAN VEEN-RUTGERS, A</creatorcontrib><creatorcontrib>BEUNDERS, A. J</creatorcontrib><creatorcontrib>BUITING, A. G. M</creatorcontrib><creatorcontrib>HOLD, C</creatorcontrib><creatorcontrib>LIGTVOET, E. E. J</creatorcontrib><creatorcontrib>PETIT, P. L</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of antimicrobial chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>DE NEELING, A. J</au><au>VAN LEEUWEN, W. J</au><au>SABBE, L. J. M</au><au>VAN GRIETHUYSEN, A. J. A</au><au>VAN EMBDEN, J. D. A</au><au>SCHOULS, L. M</au><au>SCHOT, C. S</au><au>VAN VEEN-RUTGERS, A</au><au>BEUNDERS, A. J</au><au>BUITING, A. G. M</au><au>HOLD, C</au><au>LIGTVOET, E. E. J</au><au>PETIT, P. L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Resistance of staphylococci in The Netherlands : surveillance by an electronic network during 1989-1995</atitle><jtitle>Journal of antimicrobial chemotherapy</jtitle><addtitle>J Antimicrob Chemother</addtitle><date>1998</date><risdate>1998</risdate><volume>41</volume><issue>1</issue><spage>93</spage><epage>101</epage><pages>93-101</pages><issn>0305-7453</issn><eissn>1460-2091</eissn><coden>JACHDX</coden><abstract>An electronic surveillance network for monitoring antibiotic resistance in The Netherlands has been in operation since 1989. Seven public health laboratories participate and the system covers about 25% of all bacteriological determinations in The Netherlands. This paper reports the results of staphylococci isolated in the period 1989-1995. About 0.3% of the Staphylococcus aureus isolates in the study period were resistant to methicillin. This low percentage may be due to the restrictive use of antibiotics and to strict isolation measures aimed at eradicating methicillin-resistant S. aureus. Low frequencies of resistance among methicillin-resistant S. aureus were found for vancomycin (0%), chloramphenicol (11%), cotrimoxazole (11%), mupirocin (3% low-level resistance) and fusidic acid (7%). Twenty-one percent of the coagulase-negative staphylococci were resistant to methicillin. Low frequencies of resistance among these methicillin-resistant coagulase-negative staphylococci were those to vancomycin (0.4%), nitrofurantoin (2%), doxycycline (20%) and amikacin (20%). Coagulase-negative staphylococci from cerebrospinal fluid, blood and skin were less often resistant to quinolones than isolates from respiratory tract, faeces and urine. A significant increase in resistance of coagulase-negative staphylococci to methicillin, erythromycin, gentamicin and ciprofloxacin was observed in the investigated period but the resistance to doxycycline and co-trimoxazole decreased in the last few years. To confirm the determination of methicillin resistance and coagulase production, a PCR method was developed which detects both the mecA and the coagulase gene. The results of the PCR method correlated well with the methicillin MIC as determined by an agar-dilution method.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>9511042</pmid><doi>10.1093/jac/41.1.93</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0305-7453
ispartof Journal of antimicrobial chemotherapy, 1998, Vol.41 (1), p.93-101
issn 0305-7453
1460-2091
language eng
recordid cdi_proquest_miscellaneous_79735850
source Oxford Journals Online
subjects Anti-Bacterial Agents - pharmacology
Antibacterial agents
Antibiotics. Antiinfectious agents. Antiparasitic agents
Bacterial Proteins
Biological and medical sciences
Carrier Proteins - genetics
Coagulase - metabolism
Disease Outbreaks
Drug Resistance, Multiple - genetics
Hexosyltransferases
Humans
Medical sciences
Methicillin Resistance - genetics
Microbial Sensitivity Tests
Muramoylpentapeptide Carboxypeptidase - genetics
Netherlands - epidemiology
Penicillin-Binding Proteins
Peptidyl Transferases
Pharmacology. Drug treatments
Polymerase Chain Reaction
Population Surveillance
Staphylococcal Infections - epidemiology
Staphylococcus aureus - drug effects
Staphylococcus aureus - enzymology
Staphylococcus aureus - genetics
title Resistance of staphylococci in The Netherlands : surveillance by an electronic network during 1989-1995
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T07%3A40%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Resistance%20of%20staphylococci%20in%20The%20Netherlands%20:%20surveillance%20by%20an%20electronic%20network%20during%201989-1995&rft.jtitle=Journal%20of%20antimicrobial%20chemotherapy&rft.au=DE%20NEELING,%20A.%20J&rft.date=1998&rft.volume=41&rft.issue=1&rft.spage=93&rft.epage=101&rft.pages=93-101&rft.issn=0305-7453&rft.eissn=1460-2091&rft.coden=JACHDX&rft_id=info:doi/10.1093/jac/41.1.93&rft_dat=%3Cproquest_cross%3E16476578%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c381t-3a50ee7ee7768ee64b5fef87935fa0b7e8e96708be3590b379d5f66f30a77e4f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=16476578&rft_id=info:pmid/9511042&rfr_iscdi=true